Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Thyroid dysfunction in very low birth weight preterm infants

  • Lee, Ji Hoon (Department of Pediatrics, Inje University Busan Paik Hospital, Inje University College of Medicine) ;
  • Kim, Sung Woo (Department of Pediatrics, Inje University Busan Paik Hospital, Inje University College of Medicine) ;
  • Jeon, Ga Won (Department of Pediatrics, Inje University Busan Paik Hospital, Inje University College of Medicine) ;
  • Sin, Jong Beom (Department of Pediatrics, Inje University Busan Paik Hospital, Inje University College of Medicine)
  • Received : 2014.07.01
  • Accepted : 2014.10.03
  • Published : 2015.06.10
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Thyroid dysfunction is common in preterm infants. Congenital hypothyroidism causes neurodevelopmental impairment, which is preventable if properly treated. This study was conducted to describe the characteristics of thyroid dysfunction in very low birth weight infants (VLBWIs), evaluate risk factors of hypothyroidism, and suggest the reassessment of thyroid function with an initially normal thyroid-stimulating hormone (TSH) as part of a newborn screening test. Methods: VLBWIs (January 2010 to December 2012) were divided into two groups according to dysfunction-specific thyroid hormone replacement therapy, and associated factors were evaluated. Results: Of VLBWIs, 246 survivors were enrolled. Only 12.2% (30/246) of enrolled subjects exhibited thyroid dysfunction requiring thyroid hormone replacement. Moreover, only one out of 30 subjects who required thyroid hormone treatment had abnormal thyroid function in the newborn screening test with measured TSH. Most of the subjects in the treatment group (22/30) exhibited delayed TSH elevation. Gestational age, Apgar score, antenatal steroids therapy, respiratory distress syndrome, patent ductus arteriosus, sepsis, intraventricular hemorrhage, postnatal steroids therapy, and duration of mechanical ventilation did not differ between the two groups. Birth weight was smaller and infants with small for gestational age were more frequent in the treatment group. Conclusion: Physicians should not rule out suggested hypothyroidism, even when thyroid function of a newborn screening test is normal. We suggest retesting TSH and free thyroxine in high risk preterm infants with an initially normal TSH level using a newborn screening test.

Keywords

References

  1. Simoneau-Roy J, Marti S, Deal C, Huot C, Robaey P, Van Vliet G. Cognition and behavior at school entry in children with congenital hypothyroidism treated early with high-dose levothyroxine. J Pediatr 2004;144:747-52. https://doi.org/10.1016/S0022-3476(04)00142-8
  2. Carrascosa A, Ruiz-Cuevas P, Clemente M, Salcedo S, Almar J. Thyroid function in 76 sick preterm infants 30-36 weeks: results from a longitudinal study. J Pediatr Endocrinol Metab 2008;21: 237-43.
  3. van Wassenaer AG, Kok JH. Hypothyroxinaemia and thyroid function after preterm birth. Semin Neonatol 2004;9:3-11. https://doi.org/10.1016/S1084-2756(03)00114-3
  4. Vigone MC, Caiulo S, Di Frenna M, Ghirardello S, Corbetta C, Mosca F, et al. Evolution of thyroid function in preterm infants detected by screening for congenital hypothyroidism. J Pediatr 2014;164:1296-302. https://doi.org/10.1016/j.jpeds.2013.12.048
  5. American Academy of Pediatrics, Rose SR; Section on Endocrinology and Committee on Genetics, American Thyroid Association, Brown RS; Public Health Committee, Lawson Wilkins Pediatric Endocrine Society, Foley T, et al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 2006;117:2290-303. https://doi.org/10.1542/peds.2006-0915
  6. Guy VV, Johnny D. Disorders of the thyroid in the newborn and infant. In: Sperling MA, editor. Pediatric endocrinology. 4th ed. Philadelphia (PA): Saunders, 2014:186-208.
  7. Lubchenco LO, Hansman C, Dressler M, Boyd E. Intrauterine growth as estimated from liveborn birth-weight data at 24 to 42 weeks of gestation. Pediatrics 1963;32:793-800.
  8. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004;292:2357-65. https://doi.org/10.1001/jama.292.19.2357
  9. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-34. https://doi.org/10.1016/S0022-3476(78)80282-0
  10. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986;33:179-201. https://doi.org/10.1016/S0031-3955(16)34975-6
  11. An international classification of retinopathy of prematurity. Pediatrics 1984;74:127-33.
  12. Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet 2006;367:1421-31. https://doi.org/10.1016/S0140-6736(06)68615-7
  13. Chung ML, Yoo HW, Kim KS, Lee BS, Pi SY, Lim G, et al. Thyroid dysfunctions of prematurity and their impacts on neurodevelopmental outcome. J Pediatr Endocrinol Metab 2013;26:449-55.
  14. Delahunty C, Falconer S, Hume R, Jackson L, Midgley P, Mirfield M, et al. Levels of neonatal thyroid hormone in preterm infants and neurodevelopmental outcome at 5 1/2 years: millennium cohort study. J Clin Endocrinol Metab 2010;95:4898-908. https://doi.org/10.1210/jc.2010-0743
  15. Dilli D, Eras Z, Andiran N, Dilmen U, Sakrucu ED. Neurodevelopmental evaluation of very low birth weight infants with transient hypothyroxinemia at corrected age of 18-24 months. Indian Pediatr 2012;49:711-5. https://doi.org/10.1007/s13312-012-0162-x
  16. Osborn DA, Hunt RW. Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemia. Cochrane Database Syst Rev 2007;(1):CD005945.
  17. Osborn DA, Hunt RW. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2007;(1):CD005948.
  18. van Wassenaer AG, Briet JM, van Baar A, Smit BJ, Tamminga P, de Vijlder JJ, et al. Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants. Pediatrics 2002;110:534-9. https://doi.org/10.1542/peds.110.3.534
  19. Seth A. Transient hypothyroxinemia of prematurity does it have clinical relevance? Indian Pediatr 2012;49:703-4. https://doi.org/10.1007/s13312-012-0148-8
  20. Lombardi G, Iodice M, Miletto P, Merola B, Panza N, Annunziato L. Prolactin and TSH response to TRH and metoclopramide before and after l-thyroxine therapy in subclinical hypothyroidism. Neuroendocrinology 1986;43:676-8. https://doi.org/10.1159/000124603
  21. Williams FL, Ogston SA, van Toor H, Visser TJ, Hume R. Serum thyroid hormones in preterm infants: associations with postnatal illnesses and drug usage. J Clin Endocrinol Metab 2005;90:5954-63. https://doi.org/10.1210/jc.2005-1049
  22. Williams FL, Simpson J, Delahunty C, Ogston SA, Bongers-Schokking JJ, Murphy N, et al. Developmental trends in cord and postpartum serum thyroid hormones in preterm infants. J Clin Endocrinol Metab 2004;89:5314-20. https://doi.org/10.1210/jc.2004-0869
  23. Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 2004;350:1304-13. https://doi.org/10.1056/NEJMoa032089
  24. Friedman S, Shinwell ES. Prenatal and postnatal steroid therapy and child neurodevelopment. Clin Perinatol 2004;31:529-44. https://doi.org/10.1016/j.clp.2004.04.016
  25. Cuestas RA, Engel RR. Thyroid function in preterm infants with respiratory distress syndrome. J Pediatr 1979;94:643-6. https://doi.org/10.1016/S0022-3476(79)80042-6
  26. Abbassi V, Merchant K, Abramson D. Postnatal triiodothyronine concentrations in healthy preterm infants and in infants with respiratory distress syndrome. Pediatr Res 1977;11:802-4. https://doi.org/10.1203/00006450-197707000-00004
  27. Silva SA, Chagas AJ, Goulart EM, Silva GA, Marcal LV, Gomes MN, et al. Screening for congenital hypothyroidism in extreme premature and/or very low birth weight newborns: the importance of a specific protocol. J Pediatr Endocrinol Metab 2010;23:45-52.
  28. Mandel SJ, Hermos RJ, Larson CA, Prigozhin AB, Rojas DA, Mitchell ML. Atypical hypothyroidism and the very low birthweight infant. Thyroid 2000;10:693-5. https://doi.org/10.1089/10507250050137770
  29. Larson C, Hermos R, Delaney A, Daley D, Mitchell M. Risk factors associated with delayed thyrotropin elevations in congenital hypothyroidism. J Pediatr 2003;143:587-91. https://doi.org/10.1067/S0022-3476(03)00332-9

Cited by

  1. Congenital hypothyroidism with delayed thyroid-stimulating hormone elevation in premature infants born at less than 30 weeks gestation vol.37, pp.3, 2015, https://doi.org/10.1038/jp.2016.213
  2. Clinical course of infants with congenital heart disease who developed thyroid dysfunction within 100 days vol.22, pp.4, 2017, https://doi.org/10.6065/apem.2017.22.4.253
  3. Small for gestational age is a risk factor for the development of delayed thyrotropin elevation in infants weighing less than 2000 g vol.89, pp.4, 2015, https://doi.org/10.1111/cen.13793
  4. Antenatal steroids and thyroid hormone function in preterm infants vol.38, pp.11, 2018, https://doi.org/10.1038/s41372-018-0225-5
  5. Neonatal Thyroid Function and Disorders vol.62, pp.2, 2015, https://doi.org/10.1097/grf.0000000000000434
  6. The effect of thyroid functions on osteopenia of prematurity in preterm infants vol.32, pp.1, 2015, https://doi.org/10.1515/jpem-2018-0429
  7. The effect of thyroid functions on osteopenia of prematurity in preterm infants vol.32, pp.1, 2015, https://doi.org/10.1515/jpem-2018-0429
  8. Screening and management of thyroid dysfunction in preterm infants vol.24, pp.1, 2019, https://doi.org/10.6065/apem.2019.24.1.15
  9. Congenital Hypothyroidism in Preterm Newborns: A Retrospective Study Arising from a Screening Program in Fars Province, Southwestern Iran vol.34, pp.3, 2015, https://doi.org/10.5001/omj.2019.50
  10. Thyroid-Stimulating Hormone Reference Ranges for Preterm Infants vol.144, pp.2, 2015, https://doi.org/10.1542/peds.2019-0290
  11. Lack of association between hypothyroxinemia of prematurity and transient thyroid abnormalities with adverse long term neurodevelopmental outcome in very low birth weight infants vol.14, pp.9, 2015, https://doi.org/10.1371/journal.pone.0222018
  12. Levothyroxine Sodium Administration and Late Circulatory Collapse in Premature Infants with Thyroid Dysfunction vol.30, pp.3, 2015, https://doi.org/10.14734/pn.2019.30.3.160
  13. Thyroid dysfunction in preterm infants born before 32 gestational weeks vol.19, pp.1, 2015, https://doi.org/10.1186/s12887-019-1792-0
  14. Thyroxine Threshold Is Linked to Impaired Outcomes in Preterm Infants vol.8, pp.None, 2015, https://doi.org/10.3389/fped.2020.00224
  15. Thyroid Function of Preterm Twins Having Breastmilk from Their Mothers Consuming Seaweed Soup Might Be Variable between Siblings: A Case Series vol.31, pp.1, 2015, https://doi.org/10.14734/pn.2020.31.1.55
  16. Hyperthyrotropinemia is common in preterm infants who are born small for gestational age vol.33, pp.3, 2020, https://doi.org/10.1515/jpem-2019-0461
  17. Hyperthyrotropinemia is common in preterm infants who are born small for gestational age vol.33, pp.3, 2020, https://doi.org/10.1515/jpem-2019-0461
  18. Antenatal corticosteroids for threatened labour facilitate thyroid maturation among preterm neonates vol.93, pp.5, 2015, https://doi.org/10.1111/cen.14272
  19. Serial Thyroid Function Test in Very Low Birth Weight Neonates vol.11, pp.1, 2021, https://doi.org/10.1055/s-0041-1731337
  20. Targeted Secondary Screening for Congenital Hypothyroidism in High-Risk Neonates: A 9 Year Review in a Large California Health Care System vol.7, pp.4, 2021, https://doi.org/10.3390/ijns7040081